Serotonergic agents in the treatment of social phobia in children and adolescents: A case series

被引:0
作者
Mancini, C
Van Ameringen, M
Oakman, JM
Farvolden, P
机构
[1] McMaster Univ, Med Ctr, Anxiety Disorders Clin,Anxiety Disorders Program, 3G Clin,Hamilton Hlth Sci Corp,Dept Psychiat, Hamilton, ON L8N 3Z5, Canada
[2] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada
关键词
children; adolescents; social phobia; pharmacological treatment; serotonergic agents;
D O I
10.1002/(SICI)1520-6394(1999)10:1<33::AID-DA6>3.0.CO;2-H
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Serotonergic agents have become the tr treatment of choice for adult patients with social phobia, However, there are few reports of the use of these agents in the treatment of children and adolescents with this disorder. The pharmacological treatment of social anxiety in children and adolescents is briefly reviewed and a consecutive series of child and adolescent patients who were treated with a variety of serotonin acting agents is described Seven patients, aged 7 to 18 years, with a Primary DSM-IV diagnosis of generalized social phobia were treated with paroxetine, sertraline, or nefazodone for up to 7 months, Response to treatment was evaluated by retrospective chart review by the treating clinicians. All of the patients appeared to have a very positive clinical response to the serotonergic agents, No adverse events were reported and side effects were well tolerated Results suggest that serotonergic agents may be an effective and safe treatment for children and adolescents with social phobia. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 54 条
  • [1] Albano AM, 1996, PSYCHOSOCIAL TREATME, P43
  • [2] ALBANO AM, 1995, SOCIAL PHOBIA DIAGNO, P387
  • [3] Anxiety disorders in children and adolescents: A review of the past 10 years
    Bernstein, GA
    Borchardt, CM
    Perwien, AR
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1996, 35 (09) : 1110 - 1119
  • [4] FLUOXETINE FOR CHILDHOOD ANXIETY DISORDERS
    BIRMAHER, B
    WATERMAN, GS
    RYAN, N
    CULLY, M
    BALACH, L
    INGRAM, J
    BRODSKY, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1994, 33 (07) : 993 - 999
  • [5] ELECTIVE MUTISM AS A VARIANT OF SOCIAL PHOBIA
    BLACK, B
    UHDE, TW
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1992, 31 (06) : 1090 - 1094
  • [6] TREATMENT OF ELECTIVE MUTISM WITH FLUOXETINE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    BLACK, B
    UHDE, TW
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1994, 33 (07) : 1000 - 1006
  • [7] BLACK B, 1992, J CLIN PSYCHOPHARM, V12, P293
  • [8] The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder
    Bouffard, R
    Hechtman, L
    Minde, K
    Iaboni-Kassab, F
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08): : 546 - 554
  • [9] Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia
    Bouwer, C
    Stein, DJ
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 1998, 49 (01) : 79 - 82
  • [10] Chapman T. F., 1995, SOCIAL PHOBIA DIAGNO, P21